Companies: 10,795·Total market cap: $144.5T
Provention Bio, Inc.

Provention Bio, Inc.

PRVBNASDAQHealthcare
$24.98
+$0.00(+0.00%)
Market Cap$2.4B
P/E Ratio
52W High$25.0
52W Low$3.185
Overview

Provention Bio, Inc.(PRVB)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PRVB · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$12.89M$1.40M$0.00M$0.00M$0.00M
Cost of Revenue$0.51M$0.00M$0.00M$0.00M$0.00M
Gross Profit$12.38M$1.40M$0.00M$0.00M$0.00M
Gross Margin %(computed)96.03%100.00%
Operating Expenses
R&D Expenses$75.80M$69.63M$66.36M$36.36M$22.65M
G&A Expenses$64.11M$47.35M$33.33M$8.01M$4.17M
Total Operating Expenses$140.54M$116.97M$99.69M$44.37M$26.81M
Operating Income($128.16M)($115.58M)($99.69M)($44.37M)($26.81M)
Operating Margin %(computed)-993.88%
Interest Income$2.24M$0.15M$0.58M$1.09M$0.67M
Interest Expense$1.04M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($126.96M)($115.43M)($99.10M)($43.28M)($26.66M)
Income Tax Expense($13.39M)($1.00M)($0.52M)($1.09M)($0.19M)
Net Income($113.56M)($114.43M)($98.58M)($42.20M)($26.48M)
Net Margin %(computed)-880.69%
Per Share & EBITDA
EPS (Basic)$-1.52$-1.81$-1.88$-1.04$-1.18
Wtd Avg Shares74.72M63.10M52.46M40.75M22.44M
EBITDA($124.69M)($115.19M)($99.65M)($44.37M)($26.66M)
EBITDA Margin %(computed)-966.98%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Provention Bio, Inc.

关于Provention Bio, Inc.(PRVB)损益表

Provention Bio, Inc.(PRVB)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,PRVB实现营收$0.01B,毛利润$0.01B(毛利率96.03%),净利润($0.11B)(净利率-880.69%)。

常见问题

PRVB · 4 问

Provention Bio, Inc.(PRVB)2022财年营收为$0.01B,同比up824.4%。

PRVB revenuePRVB salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08